№ lp_1_17906
File format: docx
Character count: 12051
File size: 29 KB
The document outlines feedback from the Royal Pharmaceutical Society on proposed changes to guidance for registered pharmacies providing services remotely, with suggestions to improve risk management, clarify roles, and separate guidance areas for prescribing and supply.
Year:
2023
Region / City:
United Kingdom
Topic:
Pharmaceutical guidance
Document type:
Consultation response
Organization:
Royal Pharmaceutical Society
Author:
Royal Pharmaceutical Society
Target audience:
Pharmacy professionals, regulatory bodies, pharmacy service owners
Action period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region:
England
Subject:
Diversity of pharmacists and pharmacy technicians
Document type:
Statistical report
Organization:
General Pharmaceutical Council (GPhC)
Target audience:
Healthcare regulators, policymakers, researchers
Date of data snapshot:
30 September 2023
Data categories:
Sex, race/ethnicity, age, disability, religion/belief, sexual orientation
Population covered:
Registered pharmacists and pharmacy technicians with an address in England
Data source:
Self-declared registration information on MyGPhC
Reporting frequency:
Annual updates and future trend analysis
Methodology:
Online registration data collection, voluntary disclosure options
Year:
2024
Region / city:
Great Britain
Subject:
Pharmacy professionals registration
Document type:
Official register data
Organization:
General Pharmaceutical Council (GPhC)
Author:
General Pharmaceutical Council (GPhC)
Target audience:
Pharmacists, pharmacy technicians, regulatory bodies, and related stakeholders
Period of validity:
31 July 2024
Approval date:
31 July 2024
Date of changes:
Monthly updates (latest data as of 31 July 2024)
Year:
2023
Region / City:
Wales
Topic:
Diversity data in healthcare professions
Document type:
Report
Organization / Institution:
General Pharmaceutical Council (GPhC)
Author:
GPhC
Target audience:
Pharmacy professionals, healthcare regulators
Period of validity:
30 September 2023
Date of approval:
30 September 2023
Date of changes:
None
Year:
2025
Region / City:
Dorset, BCP Council
Theme:
Pharmaceutical Services, Health Needs Assessment
Document Type:
Draft Report
Organization:
Public Health Dorset
Author:
Jane Horne, Lee Robertson, Wilson Otitonaiye, Rohan Mongru, Fiona Arnold, Louise Bate
Target Audience:
Health professionals, policymakers, local authorities
Period of Validity:
2025-2028
Approval Date:
Draft version, ongoing review
Date of Last Update:
04/06/2025
Context:
This document provides a comprehensive pharmaceutical needs assessment for the Dorset area, focusing on the supply, demand, and gaps in pharmaceutical services over the period 2025-2028.
Year:
2014
Region / City:
Global
Topic:
Pharmaceutical Product Prequalification
Document Type:
Guideline
Organization / Institution:
World Health Organization (WHO)
Author:
World Health Organization
Target Audience:
Pharmaceutical manufacturers, regulatory bodies
Effective Period:
Not specified
Approval Date:
2014
Modification Date:
Not specified
Note:
Year
Topic:
Pharmaceutical product, regulatory approval, prequalification
Document type:
Template
Organization / institution:
WHO
Target audience:
Regulatory authorities, pharmaceutical manufacturers
HDA Standard Pharmaceutical (Rx-only) Product and Medical Device Information Short Form Instructions
Note:
Year
Theme:
Pharmaceutical products, Medical devices
Document type:
Instructions, Form
Organization / Institution:
HDA
Target audience:
Distributors, Manufacturers, Supply chain professionals
Document type:
Regulatory template appendix
Subject:
Quality information summary for finished pharmaceutical products and vaccines
Procedure:
Reference SRA collaborative procedure
Regulatory framework:
WHO Guidelines on submission of documentation for prequalification
Issuing organization:
World Health Organization
Series:
WHO Technical Report Series
Series number:
No. 1010
Year:
2018
Scope:
Pharmaceutical products and vaccines approved by stringent regulatory authorities
Intended use:
National registration under the SRA collaborative procedure
Confidentiality status:
Includes confidential quality information
Approval basis:
Information as approved by the reference SRA
Change management:
Revision required upon approved variations affecting QIS-SRA (crp)
Organization:
World Health Organization; South African Health Products Regulatory Authority
Document type:
Regulatory guideline
Subject area:
Pharmaceutical quality documentation
Scope:
Multisource (generic) finished pharmaceutical products and active pharmaceutical ingredients
Applicable products:
Human medicines; biologics; veterinary medicines
Regulatory references:
WHO TRS 970 Annex 6; VICH guidelines; European Pharmacopoeia; USP; BP
Geographical applicability:
International; South Africa
Related regulatory procedures:
API Prequalification; CEP; APIMF; product dossier submission
Content focus:
Quality data requirements; labelling and product information; drug substance characterization
Intended users:
Marketing authorization applicants; regulatory assessors
Year:
2021
Region / City:
United States
Topic:
Pharmaceutical and Medical Device Product Information
Document Type:
Instructional Form
Organization / Institution:
Health Distribution Alliance (HDA)
Author:
Health Distribution Alliance
Target Audience:
Pharmaceutical distributors, medical device manufacturers, suppliers
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
2021
Year:
2023
Region / City:
Falkirk
Theme:
Health & Social Care, Pharmacy, Medication Management
Document Type:
Policy
Organization:
Falkirk Health & Social Care Partnership
Author:
Not specified
Target Audience:
Community pharmacies, care at home providers, healthcare professionals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / city:
Great Britain
Topic:
Remote hearings, Pharmacy, Patient safety
Document type:
Response to consultation
Organization:
Royal Pharmaceutical Society
Author:
Jonathan Lloyd Jones
Target audience:
General Pharmaceutical Council, Pharmacy professionals, Stakeholders
Validity period:
N/A
Approval date:
February 7, 2022
Amendment date:
N/A
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical benefits, chemotherapy, PBS
Document Type:
FAQ
Organization:
Pharmaceutical Benefits Scheme
Author:
Pharmaceutical Benefits Advisory Committee (PBAC)
Target Audience:
Healthcare providers, prescribers, patients
Effective Period:
From December 1, 2024
Approval Date:
Not specified
Modification Date:
Not specified
Contextual Description:
FAQ document providing detailed information on the changes in PBS listing for Opdualag and Vyxeos under the EFC Program, including prescription and claiming details.
Year:
2023
Country:
United Kingdom
Organisation:
Royal Pharmaceutical Society
Document type:
Evidence submission
Topic:
Inclusion and diversity in pharmacy services
Population focus:
LGBTQ+ communities
Methodology:
Mixed-methods survey and literature review
Sample size:
620 survey respondents
Data sources:
RPS I&D Programme evaluation survey; published academic studies
Status:
Unpublished internal survey with referenced published research
Scope:
Community and pharmacy professional services
Context:
Evidence submission to an LGBT+ health review drawing on an internal inclusion and diversity survey and recent pharmacy-focused research to describe experiences, barriers, and attitudes related to LGBTQ+ access to pharmacy services in the UK.
Year:
2026
Region / City:
United Kingdom
Topic:
Genomics Education, Pharmacogenomics, NHS Workforce Development
Document Type:
Written Evidence Submission
Organization / Institution:
Royal Pharmaceutical Society
Author:
Royal Pharmaceutical Society
Target Audience:
NHS professionals, educational providers, healthcare policy makers
Period of Action:
2026-2030
Approval Date:
2026
Date of Amendments:
N/A
Note:
Year
Topic:
Pharmaceutical product certification
Document Type:
Certificate
Authority / Organization:
Health Products Regulatory Authority (HPRA)
Target Audience:
Regulatory authorities, pharmaceutical companies
Note:
Year
Theme:
Pharmaceutical Products
Document Type:
Certificate
Organization / Institution:
Federal Agency for Medicines and Health Products (FAMHP)
Author:
Ethel Mertens
Target Audience:
Regulatory authorities, pharmaceutical manufacturers
Year:
2024
Region / City:
N/A
Subject:
Pharmaceutical Products, Medical Devices, Distribution
Document Type:
Instructional Form
Institution:
Healthcare Distribution Alliance (HDA)
Author:
N/A
Target Audience:
Manufacturers, Repackagers, Distributors
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
2024
Year:
2024
Region / City:
Windsor & Maidenhead
Topic:
Urban Planning, Public Consultation
Document Type:
Consultation Response Form
Organization / Institution:
Royal Borough of Windsor & Maidenhead
Author:
Royal Borough of Windsor & Maidenhead
Target Audience:
Local residents, businesses, and other stakeholders
Period of Validity:
22nd November 2024 to 19th January 2025
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2022
Region / city:
Royal United Hospitals NHS Foundation Trust
Theme:
Preceptorship, Staff Development, Healthcare
Document type:
Interview
Organization / institution:
Royal United Hospitals NHS Foundation Trust
Author:
Alexandra Bushell
Target audience:
Healthcare professionals, Preceptorship facilitators
Action period:
2021-2022
Approval date:
February 2022
Revision date:
N/A